Skip to main content
Erschienen in: International Journal of Colorectal Disease 11/2019

17.10.2019 | Original Article

Colon cancer in the young: contributing factors and short-term surgical outcomes

verfasst von: Kamil Hanna, Muhammad Zeeshan, Mohammad Hamidi, Viraj Pandit, Pamela Omesiete, Alejandro Cruz, Agnes Ewongwo, Bellal Joseph, Valentine Nfonsam

Erschienen in: International Journal of Colorectal Disease | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The incidence in young patients has increased significantly over the last few decades. The aim of this study is to evaluate demographic and tumor characteristics of young patients and analyze the short-term surgical outcomes of patients undergoing surgery.

Methods

We performed a 2-year review (2015–2016) of the ACS-NSQIP and included all patients with CC who underwent surgical management. Patients were stratified into two groups: early-onset CC (< 50 years old) and late-onset CC (≥ 50 years old). Outcome measures were hospital length of stay, 30-day complications, mortality, and readmission.

Results

We included a total of 15,957 patients in the analysis. Mean age was 65 ± 13 years, and 52% were male. Overall 10% of the patients had early-onset CC. Patients with early-onset CC were more likely to be black (11% vs 7%, p = 0.04) and Hispanic (8% vs 4%, p = 0.02). Additionally, they presented with a more aggressive tumor and higher TNM staging. Patients with early onset CC had lower 30-day complications (18% vs 22%, p = 0.02), shorter hospital length of stay (6[3–8] vs 8[5–11], p = 0.03) and lower 30-day mortality (0.4% vs 1.8%, p = 0.04) compared to their counterparts. However, there was no difference between the two groups regarding 30-day readmission. On regression analysis, there was no difference between the two groups regarding study outcomes.

Conclusions

Racial disparity does exist in the incidence of colon cancer in the young with higher incidence in blacks. Younger patients with CC tend to have better surgical outcomes on univariate analysis. On regression analysis, the surgical outcomes between the two groups are comparable.
Literatur
2.
Zurück zum Zitat Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–EE86CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–EE86CrossRef
3.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34CrossRef Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69(1):7–34CrossRef
4.
Zurück zum Zitat Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(04):191–197CrossRef Haggar FA, Boushey RP (2009) Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 22(04):191–197CrossRef
5.
Zurück zum Zitat Segal RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRef Segal RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30CrossRef
6.
Zurück zum Zitat Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Bmj. 348:g2467CrossRef Brenner H, Stock C, Hoffmeister M (2014) Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. Bmj. 348:g2467CrossRef
7.
Zurück zum Zitat Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA (2017) Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 15(6):903–909CrossRef Murphy CC, Sandler RS, Sanoff HK, Yang YC, Lund JL, Baron JA (2017) Decrease in incidence of colorectal cancer among individuals 50 years or older after recommendations for population-based screening. Clin Gastroenterol Hepatol 15(6):903–909CrossRef
8.
Zurück zum Zitat Welch HG, Robertson DJ (2016) Colorectal cancer on the decline—why screening can’t explain it all. N Engl J Med 374(17):1605–1607CrossRef Welch HG, Robertson DJ (2016) Colorectal cancer on the decline—why screening can’t explain it all. N Engl J Med 374(17):1605–1607CrossRef
9.
Zurück zum Zitat Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 120(9):1290–1314CrossRef Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, Jemal A, Cho H, Anderson RN, Kohler BA, Eheman CR, Ward EM (2014) Annual report to the nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer. 120(9):1290–1314CrossRef
10.
Zurück zum Zitat Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T et al (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27(6):872CrossRef Sargent D, Sobrero A, Grothey A, O'Connell MJ, Buyse M, Andre T et al (2009) Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 27(6):872CrossRef
11.
Zurück zum Zitat Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343(13):905–914CrossRef Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al (2000) Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. N Engl J Med 343(13):905–914CrossRef
12.
Zurück zum Zitat de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947CrossRef de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938–2947CrossRef
13.
Zurück zum Zitat Hall WH (1990) Adjuvant therapy for patients with colon and rectal-cancer. JAMA 264(11):1444–1450 Hall WH (1990) Adjuvant therapy for patients with colon and rectal-cancer. JAMA 264(11):1444–1450
14.
Zurück zum Zitat Ahnen DJ, Wade SW, Jones WF, Sifri R, Silveiras JM, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN (2014) The increasing incidence of youngonset colorectal cancer: a call to action. In Mayo Clinic Proceedings 2014 Feb 1 (Vol. 89, No. 2). Elsevier, Amsterdam, pp 216–224CrossRef Ahnen DJ, Wade SW, Jones WF, Sifri R, Silveiras JM, Greenamyer J, Guiffre S, Axilbund J, Spiegel A, You YN (2014) The increasing incidence of youngonset colorectal cancer: a call to action. In Mayo Clinic Proceedings 2014 Feb 1 (Vol. 89, No. 2). Elsevier, Amsterdam, pp 216–224CrossRef
15.
Zurück zum Zitat You YN, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med 172(3):287–289CrossRef You YN, Xing Y, Feig BW, Chang GJ, Cormier JN (2012) Young-onset colorectal cancer: is it time to pay attention? Arch Intern Med 172(3):287–289CrossRef
16.
Zurück zum Zitat Siegel RL, Jemal A, Ward EM (2009) Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiology and Prevention Biomarkers 18(6):1695–1698CrossRef Siegel RL, Jemal A, Ward EM (2009) Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiology and Prevention Biomarkers 18(6):1695–1698CrossRef
17.
Zurück zum Zitat Bailey CE, Hu C-Y, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150(1):17–22CrossRef Bailey CE, Hu C-Y, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ (2015) Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg 150(1):17–22CrossRef
18.
Zurück zum Zitat Deen KI, Silva H, Deen R, Chandrasinghe PC (2016) Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol 8(6):481CrossRef Deen KI, Silva H, Deen R, Chandrasinghe PC (2016) Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol 8(6):481CrossRef
19.
Zurück zum Zitat O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2003) Rates of colon and rectal cancers are increasing in young adults. Am Surg 69(10):866–872PubMed O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY (2003) Rates of colon and rectal cancers are increasing in young adults. Am Surg 69(10):866–872PubMed
20.
Zurück zum Zitat Kolligs FT (2016) Diagnostics and epidemiology of colorectal cancer. Visc Med 32(3):158–164CrossRef Kolligs FT (2016) Diagnostics and epidemiology of colorectal cancer. Visc Med 32(3):158–164CrossRef
21.
Zurück zum Zitat Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology and Prevention Biomarkers. 25(1):16–27CrossRef Torre LA, Siegel RL, Ward EM, Jemal A (2016) Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiology and Prevention Biomarkers. 25(1):16–27CrossRef
22.
Zurück zum Zitat Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ (2009) Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 7(6):682–8 e1-5CrossRef Tsoi KK, Pau CY, Wu WK, Chan FK, Griffiths S, Sung JJ (2009) Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 7(6):682–8 e1-5CrossRef
23.
Zurück zum Zitat Shaukat A, Dostal A, Menk J, Church TR (2017) BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci 62(9):2511–2517CrossRef Shaukat A, Dostal A, Menk J, Church TR (2017) BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci 62(9):2511–2517CrossRef
24.
Zurück zum Zitat Kwan LY, Stratton K, Bonnie RJ (2015) Public health implications of raising the minimum age of legal access to tobacco products. National Academies Press, Washington Kwan LY, Stratton K, Bonnie RJ (2015) Public health implications of raising the minimum age of legal access to tobacco products. National Academies Press, Washington
25.
Zurück zum Zitat Chung DC (2018) Genetic testing and early onset colon cancer. Gastroenterology. 154(4):788–789CrossRef Chung DC (2018) Genetic testing and early onset colon cancer. Gastroenterology. 154(4):788–789CrossRef
26.
Zurück zum Zitat Habib R, Gebski V, Toh J, Pathma-Nathan N, Khoury TE, Ctercteko G, Jayamohan J, Wong KYM, Wilcken N, Nagrial A (2019) Outcomes of younger patients diagnosed with locally advanced rectal cancer. Proc Am Soc Clin Oncol 37:500CrossRef Habib R, Gebski V, Toh J, Pathma-Nathan N, Khoury TE, Ctercteko G, Jayamohan J, Wong KYM, Wilcken N, Nagrial A (2019) Outcomes of younger patients diagnosed with locally advanced rectal cancer. Proc Am Soc Clin Oncol 37:500CrossRef
Metadaten
Titel
Colon cancer in the young: contributing factors and short-term surgical outcomes
verfasst von
Kamil Hanna
Muhammad Zeeshan
Mohammad Hamidi
Viraj Pandit
Pamela Omesiete
Alejandro Cruz
Agnes Ewongwo
Bellal Joseph
Valentine Nfonsam
Publikationsdatum
17.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 11/2019
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-019-03402-2

Weitere Artikel der Ausgabe 11/2019

International Journal of Colorectal Disease 11/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.